SPDR S&P Biotech ETF $XBI Shares Sold by Associated Banc Corp

Associated Banc Corp reduced its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 52.6% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 5,081 shares of the exchange traded fund’s stock after selling 5,647 shares during the quarter. Associated Banc Corp’s holdings in SPDR S&P Biotech ETF were worth $421,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the business. DHJJ Financial Advisors Ltd. bought a new position in SPDR S&P Biotech ETF in the second quarter worth about $25,000. AlphaCore Capital LLC raised its position in shares of SPDR S&P Biotech ETF by 6,650.0% during the 2nd quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock worth $45,000 after purchasing an additional 532 shares during the period. Quaker Wealth Management LLC raised its position in shares of SPDR S&P Biotech ETF by 101.2% during the 2nd quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock worth $52,000 after purchasing an additional 53,536 shares during the period. Avalon Trust Co bought a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter worth approximately $57,000. Finally, Curio Wealth LLC boosted its position in SPDR S&P Biotech ETF by 74,700.0% during the 2nd quarter. Curio Wealth LLC now owns 748 shares of the exchange traded fund’s stock valued at $62,000 after purchasing an additional 747 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $121.37 on Wednesday. The company has a market cap of $7.37 billion, a P/E ratio of 11.47 and a beta of 0.93. The stock has a fifty day moving average price of $107.30 and a 200 day moving average price of $93.42. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $121.41.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.